I am currently analyzing the effects of a low protein diet (so compared with a normal protein diet) on the level of expression of certain genes expressed at several early developmental stages. Upon being collected at the pluripotent stage from the preimplantation blastocyst (E 3.5), the cells have been maintained in culture and subsequently neurally induced. I am testing actually how does a low protein diet during the preimplantation development only, affects neural induction in vitro. The genes that I am looking at include Nanog, Oct-4, Nestin, Sox2, Sox1, Pax6, Gata4, Brachyury, Map ii, Beta3- Tubulin. However, some of these genes will not be expressed in my samples (randing from a pluripotent stage until approximately day 5 of neural induction - Pluripotent stage, Day 1 of neural induction, Day 2, Day 3, Day 4, Day 5). Some of the genes would have appeared later if Neural induction would have been continued.

=====> Therefore, how do I get to calculate primer efficiencies for the primers pertaining to a gene that is not expressed in my samples? Because if I am not doing primer efficiency calculation, I won't be able to analyze my data using 1 of the 3 methods (Livak, Pfaffl, qBASE+).

I assume I should make use of some sort of positive control? I actually do require to present a positive control (apart from a no replicate -NRT- and no template controls -NTC) as well, right?

But is it okay to use another tissue to test your primer efficiency?

CRITICAL: How can I check gene expression across tissue for pluripotency-related genes such as Nanog? Obviously they would not be expressed in adult tissue.

ALSO CRITICAL: Is there any sort of Mouse gene expression Atlas that also includes the postnatal development? (I am aware of EMAGE that is about prenatal stages only)

CRITICAL: Did anyone heard about qBASE+ software?

THANK YOU!!

More Diana Andreea Zbarcea's questions See All
Similar questions and discussions